Abstract:Somatic cells could be reprogrammed into an ES-like state called induced pluripotent stem cells (iPSCs) by expression of four transcriptional factors: Oct4, Sox2, Klf4 and cMyc. iPSCs have full potentials to generate cells of all lineages and have become a valuable tool to understand human development and disease pathogenesis. However, reprogramming process suffers from extremely low efficiency and the molecular mechanism remains poorly understood. This dissertation is focused on studying the role of small non-coding RNAs (microRNAs) and kinases during the reprogramming process in order to understand how it is regulated and why only a small percentage of cells could achieve fully reprogrammed state. We demonstrate that loss of microRNA biogenesis pathway abolished the potential of mouse embryonic fibroblasts (MEFs) to be reprogrammed and revealed that several clusters of mES-specific microRNAs were highly induced by four factors during early stage of reprogramming. Among them, miR-93 and 106b were further confirmed to enhance iPSC generation by promoting mesenchymal-to-epithelial transition (MET) and targeting key p53 and TGFβ pathway components: p21 and Tgfbr2, which are important barrier genes to the process. To expand our view of microRNAs function during reprogramming, a systematic approach was used to analyze microRNA expression profile in iPSC-enriched early cell population. From a list of candiate microRNAs, miR-135b was found to be most highly induced and promoted reprogramming. Subsequent analysis revealed that it targeted an extracellular matrix network by directly modulating key regulator Wisp1. By regulating several downstream ECM genes including Tgfbi, Nov, Dkk2 and Igfbp5, Wisp1 coordinated IGF, TGFβ and Wnt signaling pathways, all of which were strongly involved in the reprogramming process. Therefore, we have identified a microRNA-regulated network that modulates somatic cell reprogramming, involving both intracellular and extracellular networks. In addition to microRNAs, in order to identify new regulators and signaling pathways of reprogramming, we utilized small molecule kinase inhibitors. A collection of 244 kinase inhibitors were screened for both enhancers and inhibitors of the process. We identified that inhibition of several novel kinases including p38, IP3K and Aurora kinase could significantly enhance iPSC generation, the effects of which were also confirmed by RNAi of specific target genes. Further characterization revealed that inhibition of Aurora A kinase enhanced phosphorylation and inactivation of GSK3β, a process mediated by Akt kinase. All together, in this dissertation, we have identified novel role of both small non-coding RNAs and kinases in regulating the reprogramming of MEFs to iPSCs.

Kinome-wide Functional Analysis Highlights the Role of Cytoskeletal Remodeling in Somatic Cell Reprogramming.

Dissecting Somatic Cell Reprogramming by MicroRNAs and Small Molecules: A Dissertation

A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation

RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy

H3K9 Methylation is a Barrier During Somatic Cell Reprogramming into Ipscs.

B1 SINE-binding ZFP266 Impedes Mouse Ipsc Generation Through Suppression of Chromatin Opening Mediated by Reprogramming Factors.

Probabilistic Modeling of Reprogramming to Induced Pluripotent Stem Cells.

A Serial Shrna Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2

B1 SINE-binding ZFP266 impedes reprogramming through suppression of chromatin opening mediated by pioneering factors

Stimulation of Somatic Cell Reprogramming by ERas-Akt-FoxO1 Signaling Axis.

A CRISPR/Cas9-based Kinome Screen Identifies ErbB Signaling As a New Regulator of Human Naïve Pluripotency and Totipotency

Resolving Cell Fate Decisions During Somatic Cell Reprogramming by Single-Cell RNA-Seq.

Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs

Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency

RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming

Small RNA-mediated Regulation of Ips Cell Generation

Early Role for IL-6 Signalling During Generation of Induced Pluripotent Stem Cells Revealed by Heterokaryon RNA-Seq.

MAP2K6 remodels chromatin and facilitates reprogramming by activating Gatad2b-phosphorylation dependent heterochromatin loosening

Combined Noncoding RNA-mRNA Regulomics Signature in Reprogramming and Pluripotency in iPSCs

Dissecting direct reprogramming through integrative genomic analysis

A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors During Early Stage of Cardiac Reprogramming